FDG PET evaluation of mucinous neoplasms: Correlation of FDG uptake with histopathologic features

American Journal of Roentgenology

Volumn 174, Issue 4, 2000, Pages 1005-1008

  Berger, Kevin L ^a   Nicholson, Siobhan A ^b   Dehdashti, Farrokh ^a   Siegel, Barry A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MUCIN;

ADULT; AGED; ARTICLE; BIOPSY; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUCINOUS CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER;

EID: 0034112731     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.174.4.1741005     Document Type: Article

References (23)

1. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-1674
2. Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioalveolar carcinoma: FDG PET findings. AJR 1998;170:935-939
3. Jadvar H, Segall GM. False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med 1997;38:1382-1383
4. Cohen AM, Minsky BD, Schilsky RL. Colon cancer. In: Devita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 4th ed. Philadelphia: Lippincott, 1993:776-817
5. Connelly JH, Robey-Cafferty SS, Cleary KB. Mucinous carcinomas of the colon and rectum: analysis of 62 stage B and C lesions. Arch Pathol Lab Med 1991;115:1022-1025
6. World Health Organization. Histologic typing of breast tumors. Tumori 1982;68:181-198
7. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 1997;4:613-620
8. Xu M, Luk WK, Cutler PD, Digby WM. Local threshold for segmented attenuation correction of PET imaging of the thorax. IEEE Trans Nucl Sci 1994;41:1532-1537
9. Rosai J. Special techniques in surgical pathology. In: Rosai J, ed. Ackerman's surgical pathology, 8th ed. St. Louis: Mosby-Year Book, 1996:31-62
10. Green JB, Timmcke AE, Mithcel WT, Hicks TC, Gathright JB Jr, Ray JE. Mucinous carcinoma -just another colon cancer? Dis Colon Rectum 1993;36:49-54
11. Sun XF, Cartensen JM, Stal O, Zhang H, Boeryd B. Nordenskjold B. Interrelations of clinicopathologic variables and their prognostic value in colorectal adenocarcinoma. APMIS 1996;104:35-38
12. Baldus SE, Zirabes TK, Engel S, et al. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathologic subtype and prognosis of gastric carcinomas. Int J Cancer 1998;79:133-138
13. Yonezawa S, Taira M, Osaka M, et al. MUC-I mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int 1998;48:319-322
14. Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993;34:414-419
15. Adler LP, Blair HF, Makley JT, et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991;32:1508-1512
16. Higashi K, Nishikawa T, Seki H, et al. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer. J Nucl Med 1998;39:9-15
17. Delbeke D, Vitola JV, Sandler MP, et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196-1201
18. Adler LP, Crowe JP, Al-Kaisi NK, et al. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology 1993; 187:743-750
19. Di Chiro G, Brooks RA, Bairamian D, et al. Diagnostic and prognostic value of positron emission tomography using [18F]fluorodeoxyglucose in brain tumors. In: Reivich M, Alavi A, eds. Positron emission tomography. New York: Alan Lyss, 1985:291-309
20. 18F-fluorodeoxyglucose positron emission tomography. AJR 1997; 168:417-424
21. Lowe VJ, Hoffman JM, Delong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in patients with pulmonary abnormalities. J Nucl Med 1994;43:7-23
22. Vansteenkiskiste JF, Stroobant SG, De Leyn PR, et al. Lymph node staging in non-small cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998;16:2142-2149
23. Avril N, Bense S, Ziegler SI, et al. Breast imaging with fluorine-18-FDG PET: quantitative image analysis. J Nucl Med 1997;38:1186-1191